Equisul Sdt is a drug owned by AURORA PHARMACEUTICAL, INC. It is protected by 3 US drug patents filed in 2019. All patents have expired. Details of Equisul Sdt’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6800631 | 05 May, 2019 | Expired |
Exclusivity Information
Equisul Sdt holds 1 exclusivity out of which 1 has expired. Details of Equisul Sdt's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Jul 26, 2016 |
Equisul Sdt Petitions
Details of Equisul Sdt's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Clinaxel, Inc. | Filed | NA | |
About Equisul Sdt
Equisul Sdt is a drug
owned by AURORA PHARMACEUTICAL, INC.
Equisul Sdt uses
Sulfadiazine, Trimethoprim as the active
ingredients.
Active Ingredient:
Equisul Sdt uses
Sulfadiazine,
Trimethoprim
as the active ingredients.
Check out other Drugs and Companies using
Sulfadiazine, Trimethoprim ingredient.